Establishing clinical benefit is one of the most challenging and costly steps in developing new treatments. Conventional clinical outcome assessments may lack the sensitivity to detect meaningful changes in patient functioning, but digital endpoints offer new opportunities to advance drug development.
The ActiGraph team has developed these Digital Endpoint Resource Guides to support clinical teams interested in how DHTs can enhance their development programs in specific therapeutic areas. In these guides you will learn:
Accelerate Clinical Trials
Opportunities to support drug development in specific therapeutic areas with wearable-based digital endpoints
Unlock Clinical Insights
Previously inaccessible clinical insights available through selected, therapeutic-area relevant digital endpoints
Real-World Digital Measures
Physical activity, sleep, gait, mobility, and/or vital sign measures capable of being captured in a patient’s natural environment
Regulatory Guidance
Related regulatory guidance and usability validation in a specific therapeutic area
